Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 5:20 PM
Ignite Modification Date:
2025-12-26 @ 5:20 PM
NCT ID:
NCT05870306
Eligibility Criteria:
Inclusion Criteria:
* Age \> 18 years.
* Patients undergoing a first-time ablation procedure for AF.
* Patients with persistent or long-lasting AF; persistent AF will be defined as a sustained episode lasting \>7 days and \<1 year; long-lasting persistent AF will be \>1 year and \<3 years
* Patients with PxAF; PxAF will be defined as a sustained episode lasting \<7 days;
* Patients who must be willing and able to comply with all periablation and follow-up requirements
* Patients with AF who will accept the procedure of ablation
* Patients who signed the written informed consent for the study
* Patients who can endure the required follow-up.
Exclusion Criteria:
* Patients with left atrial size ≥55 mm (2-dimensional echocardiography, parasternal long-axis view)
* Patients with severe structural cardiac disease (severe mitral regurgitation, dilated cardiomyopathy, hypertrophy cardiomyopathy, other severe valvular heart diseases)
* Patients with the serum creatinine \>3.5 mg/dL or creatinine clearance rate \<30 mL/min;
* Patients with life expectancy \<12 months;
* Medical, geographical and social factors that make study participation impractical, and inability to give written informed consent. Patient's refusal to participate in the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05870306
Study Brief:
Protocol Section:
NCT05870306